Domesco Medical Import - Export Joint-Stock Corporation Sustainability Profile
Domesco Medical Import - Export Joint-Stock Corporation, commonly referred to as Domesco, is a leading player in the pharmaceutical and medical supply industry, headquartered in Vietnam. Established in 1990, the company has made significant strides in the import and export of medical products, catering to both domestic and international markets. With a diverse portfolio that includes pharmaceuticals, medical devices, and healthcare solutions, Domesco is renowned for its commitment to quality and innovation. The company has achieved notable milestones, positioning itself as a trusted partner in healthcare. Its core offerings are distinguished by rigorous quality control and adherence to international standards, ensuring reliability in every product. Domesco's strategic operations extend across various regions, solidifying its market presence and reputation as a key contributor to Vietnam's healthcare landscape.
DitchCarbon Score
How does Domesco Medical Import - Export Joint-Stock Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Domesco Medical Import - Export Joint-Stock Corporation's score of 54 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Domesco Medical Import - Export Joint-Stock Corporation, headquartered in Vietnam (VN), currently does not report specific carbon emissions data for the most recent year. The company is a current subsidiary of Abbott Laboratories, and any climate commitments or emissions data may be inherited from this parent organisation. As of now, Domesco has not established specific reduction targets or initiatives, nor does it participate in the Science Based Targets initiative (SBTi) or disclose information through the Carbon Disclosure Project (CDP). The absence of direct emissions data suggests that the company may rely on the sustainability frameworks and targets set by Abbott Laboratories, which operates at a higher corporate level. In summary, while Domesco Medical Import - Export Joint-Stock Corporation does not currently provide specific emissions figures or reduction commitments, it is positioned within a corporate family that may influence its climate strategies through the practices of Abbott Laboratories.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 |
How Carbon Intensive is Domesco Medical Import - Export Joint-Stock Corporation's Industry?
How Carbon Intensive is Domesco Medical Import - Export Joint-Stock Corporation's Location?
Domesco Medical Import - Export Joint-Stock Corporation's Scope 3 Categories Breakdown
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Domesco Medical Import - Export Joint-Stock Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Domesco Medical Import - Export Joint-Stock Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
